These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18288747)

  • 41. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient.
    Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Vitrella G; Ferraro M; Colombo A
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):436-9; discussion 440-1. PubMed ID: 15789401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of paclitaxal vs. sirolimus eluting stents with bio-degradable polymer for the treatment of coronary bifurcation lesions: subgroup analysis from DKCRUSH-I and DKCRUSH-II studies.
    Chen SL; Mintz G; Santoso T; Zhang JJ; Ye F; Xu YW; Fu Q; Kan J; Paiboon C; Zhou Y; Ding SQ; Kwan TW
    Chin Med J (Engl); 2012 Oct; 125(19):3382-7. PubMed ID: 23044292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
    JACC Cardiovasc Interv; 2011 Mar; 4(3):310-6. PubMed ID: 21435609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
    Cosgrave J; Agostoni P; Ge L; Iakovou I; Chieffo A; Biondi-Zoccai GG; Sangiorgi GM; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Bonizzoni E; Colombo A
    Am J Cardiol; 2005 Dec; 96(12):1663-8. PubMed ID: 16360354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.
    Werner GS; Krack A; Schwarz G; Prochnau D; Betge S; Figulla HR
    J Am Coll Cardiol; 2004 Dec; 44(12):2301-6. PubMed ID: 15607390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis].
    Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):305-7. PubMed ID: 17711652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials.
    Planer D; Smits PC; Kereiakes DJ; Kedhi E; Fahy M; Xu K; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1104-15. PubMed ID: 22017936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J
    J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.
    Park KW; Kang SH; Park KH; Choi DH; Lee HY; Kang HJ; Cho YS; Yeon TJ; Chung WY; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS
    Int J Cardiol; 2011 Aug; 151(1):89-95. PubMed ID: 20605240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct versus predilatation drug-eluting stenting: a randomized clinical trial.
    Katritsis DG; Korovesis S; Karvouni E; Giazitzoglou E; Theodorou S; Kourlaba G; Panagiotakos D; Voridis E
    J Invasive Cardiol; 2006 Oct; 18(10):475-9. PubMed ID: 17235419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
    Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three year follow-up of the sirolimus-eluting stent and the paclitaxel-eluting stent in daily practice.
    Gao Z; Yang Y; Xu B; Chen J; Qiao S; Li J; Wu Y; Qin X; Yuan J; Gao R
    Clin Cardiol; 2009 Dec; 32(12):E63-7. PubMed ID: 20014187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions.
    Lee CW; Park DW; Seung KB; Kim PJ; Park HJ; Kim WJ; Lee JY; Kang SJ; Lee SH; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2011 Apr; 107(7):990-4. PubMed ID: 21296317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
    Yuan F; Chen X; Song X; Wang D; Zhang Z; Li W; Li Z; Li H; Chen X; Huo Y; Wang L; Lu C; Lu Q; Xu B; Li W; Lyu S;
    Chin Med J (Engl); 2014; 127(14):2561-6. PubMed ID: 25043067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.